Ventas (NYSE:VTR) Receives Overweight Rating from Cantor Fitzgerald

Cantor Fitzgerald reiterated their overweight rating on shares of Ventas (NYSE:VTR) in a research note issued to investors on Monday, MarketBeat reports. Cantor Fitzgerald currently has a $93.00 target price on the real estate investment trust’s stock.

VTR has been the topic of a number of other reports. The Goldman Sachs Group began coverage on shares of Ventas in a research report on Friday, January 9th. They issued a “buy” rating and a $94.00 price objective on the stock. Citigroup boosted their target price on shares of Ventas from $80.00 to $88.00 and gave the stock a “buy” rating in a research note on Tuesday, November 11th. Wells Fargo & Company raised their price target on Ventas from $80.00 to $88.00 and gave the company an “overweight” rating in a research note on Tuesday, November 25th. KeyCorp lifted their price target on Ventas from $70.00 to $85.00 and gave the stock an “overweight” rating in a report on Thursday, December 4th. Finally, Scotiabank upped their price objective on Ventas from $74.00 to $80.00 and gave the stock a “sector perform” rating in a research report on Thursday, November 13th. Fourteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $82.75.

Ventas Price Performance

Shares of NYSE VTR opened at $82.70 on Monday. The company has a debt-to-equity ratio of 1.03, a current ratio of 0.67 and a quick ratio of 0.32. The company has a market cap of $38.85 billion, a price-to-earnings ratio of 153.15, a price-to-earnings-growth ratio of 2.03 and a beta of 0.77. The stock’s 50-day moving average is $78.17 and its two-hundred day moving average is $73.39. Ventas has a 1-year low of $58.72 and a 1-year high of $84.10.

Ventas (NYSE:VTR) last announced its quarterly earnings data on Thursday, February 5th. The real estate investment trust reported $0.15 EPS for the quarter, missing analysts’ consensus estimates of $0.89 by ($0.74). The company had revenue of ($1,229.71) million for the quarter, compared to analyst estimates of $1.53 billion. Ventas had a return on equity of 2.09% and a net margin of 4.31%.The business’s quarterly revenue was up 21.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.81 earnings per share. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. Analysts forecast that Ventas will post 3.4 EPS for the current fiscal year.

Ventas Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, April 16th. Stockholders of record on Tuesday, March 31st will be given a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.5%. This is an increase from Ventas’s previous quarterly dividend of $0.48. The ex-dividend date is Tuesday, March 31st. Ventas’s payout ratio is presently 355.56%.

Insider Activity

In related news, CEO Debra A. Cafaro sold 10,322 shares of the firm’s stock in a transaction that occurred on Monday, February 2nd. The stock was sold at an average price of $77.66, for a total transaction of $801,606.52. Following the transaction, the chief executive officer owned 1,114,034 shares in the company, valued at $86,515,880.44. This trade represents a 0.92% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Robert F. Probst sold 29,930 shares of Ventas stock in a transaction that occurred on Friday, January 2nd. The stock was sold at an average price of $77.25, for a total value of $2,312,092.50. Following the transaction, the chief financial officer directly owned 138,434 shares in the company, valued at approximately $10,694,026.50. This trade represents a 17.78% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 130,459 shares of company stock valued at $10,152,803. Insiders own 1.00% of the company’s stock.

Hedge Funds Weigh In On Ventas

A number of institutional investors have recently modified their holdings of VTR. Bridgewater Advisors Inc. raised its holdings in Ventas by 2.0% during the fourth quarter. Bridgewater Advisors Inc. now owns 6,790 shares of the real estate investment trust’s stock worth $525,000 after purchasing an additional 133 shares in the last quarter. Arbor Capital Management Inc. ADV boosted its stake in Ventas by 0.6% during the 3rd quarter. Arbor Capital Management Inc. ADV now owns 21,716 shares of the real estate investment trust’s stock valued at $1,520,000 after purchasing an additional 137 shares in the last quarter. True Wealth Design LLC increased its position in shares of Ventas by 32.0% during the 4th quarter. True Wealth Design LLC now owns 569 shares of the real estate investment trust’s stock valued at $44,000 after purchasing an additional 138 shares during the period. Cigna Investments Inc. New raised its stake in shares of Ventas by 3.3% in the 4th quarter. Cigna Investments Inc. New now owns 4,396 shares of the real estate investment trust’s stock worth $341,000 after buying an additional 142 shares in the last quarter. Finally, Foundations Investment Advisors LLC lifted its holdings in shares of Ventas by 3.3% in the third quarter. Foundations Investment Advisors LLC now owns 4,447 shares of the real estate investment trust’s stock valued at $311,000 after buying an additional 144 shares during the period. 94.18% of the stock is owned by institutional investors and hedge funds.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.